BREAST CANCER

Shocking Statistic: False Alarms May Be as High as 40 Percent!
A recent study and editorial published in the New England Journal of Medicine indicated that x-ray mammography screening may "save" only 1 person for every 2,500 screened.

Among the 2,500 screened at least 1,000 will have a false alarm, 500 would undergo an unnecessary biopsy, and 5 or more would become treated for abnormal finds that would never become fatal, i.e. their lives will be shortened due to medication/surgical/stress-induced adverse effects.

Given these findings X-ray mammography may be far more effective at generating increased numbers of breast cancer diagnoses than in "preventing" malignancy and mortality associated with the disease. To the contrary, a growing body of clinical evidence indicates that the "low energy" x-rays used in breast screenings are up to 500% more carcinogenic than previously assumed and upon which current radiation risk models that favor mass breast screenings with ionizing diagnostic technologies find justification.

The success of this highly popularized model of "prevention," which prevents nothing, is explained when we look deeper into who is behind AstraZeneca, the founding sponsor of National Breast Cancer Awareness Month.

AstraZeneca's Role in the Cancer Industry
AstraZeneca was in fact a by-product of one of the world's largest chemical (and carcinogen) producers, Imperial Chemical Industries (ICI). Before being acquired by AkzoNobel in 2008, ICI produced millions of pounds annually of known mammary carcinogens such as vinyl chloride. ICI demerged its pharmaceutical bioscience businesses in 1993 to form Zeneca Group plc., which later merged with Astra AB to form AstraZeneca in 1999.

AstraZeneca's best-selling cancer drug Tamoxifen is actually classified by the World Health Organization as a carcinogen. (To view toxicological data on this chemical visit our Problem Substances Database page on Tamoxifen). Presently all campaign ads and promotional events that are run by the National Breast Cancer Awareness Month foundation (which operates year round) must be "approved," i.e. "pink-washed," by AstraZeneca before being released for public consumption.

Other experts and organizations have pointed out this glaring conflict of interest:

"A decade-old multi-million dollar deal between National Breast Cancer Awareness Month sponsors and Imperical Chemical Industries (ICI) has produced reckless misinformation on breast cancer," ~ Dr. Samuel Epstein [a leading international authority on cancer-causing effects of environmental pollutants.]

"Imperial Chemical Industries has supported the cancer establishment's blame-the-victim attitude toward the causes of breast and other cancers. This theory attributes escalating cancer rates to heredity and faulty lifestyle, rather than avoidable exposures to industrial carcinogens contaminating air, water, food, consumer products, and the workplace."

~ Cancer Prevention Coalition